HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sho Aki Selected Research

iminobiotin

1/2022Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sho Aki Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 10/2012
1Starvation
07/2018
1Fibrosis (Cirrhosis)
01/2018
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018
1Aortic Aneurysm (Aneurysm, Aortic)
10/2012
1Anaphylaxis (Anaphylactic Shock)
10/2012

Drug/Important Bio-Agent (IBA)

1human ERBB2 proteinIBA
01/2022
1iminobiotinIBA
01/2022
1silicon phthalocyanineIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
07/2018
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2018
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2018
1LysophospholipidsIBA
01/2018
1Interleukin-13IBA
01/2018
1Angiotensin IIIBA
10/2012

Therapy/Procedure

1Injections
01/2018
1Therapeutics
01/2018